Amgen Inc. (NASDAQ:AMGN) is one of the 10 Best Value Stocks to Buy According to Billionaires. On June 23, the company ...

Amgen Inc. (NASDAQ:AMGN) ranks among the best set-it-and-forget-it stocks to buy. On June 24, Piper Sandler reaffirmed its ...

Eli Lilly and Novo Nordisk, which already have approved GLP-1 weight loss drugs that are raking in billions of revenues, have ...

Both well-established and small, clinical-stage pharma companies are investing heavily to be able to someday compete with ...

David Petrus IbarsIn the same way weight varies from person to person, so do the best weight loss strategies. While some ...

MariTide, a new drug from Amgen, helped some people with obesity lose up to 20% of their body weight. In a phase 2 trial, a new GLP-1 drug helped people lose up to 20% of their body weight over a year ...

Amgen Inc. (NASDAQ: AMGN) is one of the 10 Best Value Stocks to Buy According to Billionaires. On June 23, the company announced full results from Part 1 of the Phase 2 study of MariTide ...

They also have strong dividend track records. Apple and Amgen have lagged the market over the trailing-12-month period, but ...

MariTide isn't approved, but even if it is, if it doesn't shake concerns related to side effects, then there may not be strong demand for it. Has Amgen become a bad buy on this news?

Amgen's Phase 3 trial of bemarituzumab plus chemo met its survival goal in FGFR2b+ gastric cancer, with full data expected ...

US biotech major Amgen, a late comer to the growing obesity treatment space, released new data showing that its MariTide ...

Maridebart cafraglutide showed promising results in weight loss, offering a monthly treatment option for obesity with ...